tradingkey.logo
tradingkey.logo
Search

TG Therapeutics Secures An Additional $500 Million In Non-Dilutive Capital From Blue Owl And Expands Share Repurchase Program To $300 Million

ReutersMar 19, 2026 11:55 AM

- TG Therapeutics Inc TGTX.O:

  • TG THERAPEUTICS SECURES AN ADDITIONAL $500 MILLION IN NON-DILUTIVE CAPITAL FROM BLUE OWL AND EXPANDS SHARE REPURCHASE PROGRAM TO $300 MILLION

  • TG THERAPEUTICS INC - ENTERS FIVE-YEAR $750 MILLION CREDIT FACILITY WITH BLUE OWL CAPITAL

  • TG THERAPEUTICS INC - INCREASES SHARE REPURCHASE PROGRAM TO $300 MILLION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI